Advertisement News Archives - Page 1495 of 5245 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

November 17, 2026

Seawolf Therapeutics and Sanofi agree $1.2bn drug deal

US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.

Seawolf Therapeutics and Sanofi agree $1.2bn drug deal